0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
From The JAMA Web Sites |

Analysis of Ritonavir for the Treatment of HIV Disease in Children

James M. Oleske, MD, MPH
JAMA. 1998;279(22):1831. doi:10.1001/jama.279.22.1831.
Text Size: A A A
Published online

Extract

Journal Scan Archive, March 1998
http://www.ama-assn.org/aids
Posted April 6, 1998

Mueller BU, Nelson RP, Sleasman J.  et al. A phase I/II study of the protease inhibitor ritonavir in children with human immunodeficiency virus infection. Pediatrics.1998;101:335-343.
Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children. Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection.Atlanta, Ga: National Pediatric and Family HIV Resource Center, Health Resources and Services Administration; 1997.
Torres RA, Barr MR.Combination antiretroviral therapy for HIV infection. Infect Med.1997;14:145-150, 152-160.
Mueller BU.Antiviral chemotherapy. Curr Opin Pediatr.1997;9:178-183.
Williams A, Friedland G.Adherence, compliance and HAART. AIDS Clin Care.1997;9:51-54, 58.
Crespo-Fierro M.Compliance/adherence and care management in HIV disease. J Assoc Nurses AIDS Care.1997;8:43-54.
Deeks SG, Smith M, Holodniy M.  et al. HIV-1 protease inhibitors: a review for clinicians. JAMA.1997;277:145-153.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles
Elvitegravir for the treatment of HIV infection. Drugs Today (Barc) 2014;50(3):209-17.
Jobs
brightcove.createExperiences();